Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica
Authors:
- 20 November 2013
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 85 (4) , 419-430
Abstract
Objective Pathological breakdown of the blood-brain barrier (BBB) is thought to constitute the beginning of the disease process in neuromyelitis optica (NMO). In the current study, we investigated possible molecular mechanisms responsible for the breakdown of BBB using NMO sera. Methods We analysed the effects of sera obtained from anti-aquaporin 4 (AQP4) antibody-positive NMO spectrum disorder (NMOSD) patients, multiple sclerosis (MS) patients and control subjects on the production of claudin-5, matrix-metalloproteinases (MMPs)-2/9, and vascular cell adhesion protein-1 (VCAM-1) in human brain microvascular endothelial cells (BMECs). We also examined whether immunoglobulin G (IgG) purified from NMOSD sera influences the claudin-5 or VCAM-1 protein expression. Results The disturbance of BBB properties in BMECs following exposure to NMOSD sera was restored after adding the MMP inhibitor, GM6001. The secretion of MMP-2/9 by BMECs significantly increased after applying the NMOSD sera. The sera from NMOSD patients also increased both the MMP-2/9 secretion and the VCAM-1 protein level by BMECs. The IgG purified from NMOSD sera did not influence the BBB properties or the amount of MMP-2/9 proteins, although it did increase the amount of VCAM-1 proteins in BMECs. Reduction in anti-AQP4 antibody titre was not correlated with a reduction in VCAM-1 expression. Conclusions The autocrine secretion of MMP-2/9 by BMECs induced by humoral factors, other than IgG, in sera obtained from NMOSD patients potentially increases BBB permeability. IgG obtained from NMOSD sera, apart from anti-AQP4 antibodies, affect the BBB by upregulating VCAM, thereby facilitating the entry of inflammatory cells into the central nervous system.Keywords
This publication has 40 references indexed in Scilit:
- The history of neuromyelitis opticaJournal of Neuroinflammation, 2013
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disordersJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Aquaporin 4 and neuromyelitis opticaThe Lancet Neurology, 2012
- AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevanceNature Reviews Neurology, 2010
- Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelinationActa Neuropathologica, 2010
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivoAnnals of Neurology, 2009
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis opticaNeurology, 2007
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain, 2007
- Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosisBrain, 2007
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004